HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tesamorelin

a peptide; a stabilized analogue of the growth hormone releasing factor; aimed at reducing excess abdominal fat or VAT in lipodystrophy and HIV patients
Also Known As:
TH-9507; TH9507; egrifta
Networked: 30 relevant articles (9 outcomes, 12 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Grinspoon, Steven K: 7 articles (01/2021 - 01/2011)
2. Stanley, Takara L: 7 articles (01/2021 - 01/2011)
3. Feldpausch, Meghan N: 6 articles (01/2021 - 10/2017)
4. Fourman, Lindsay T: 6 articles (01/2021 - 10/2017)
5. Chung, Raymond T: 5 articles (01/2021 - 12/2019)
6. Corey, Kathleen E: 5 articles (01/2021 - 12/2019)
7. Hadigan, Colleen M: 5 articles (01/2021 - 12/2019)
8. Kleiner, David E: 5 articles (01/2021 - 12/2019)
9. Torriani, Martin: 5 articles (01/2021 - 12/2019)
10. Zheng, Isabel: 5 articles (01/2021 - 12/2019)

Related Diseases

1. Lipodystrophy
2. Non-alcoholic Fatty Liver Disease
3. HIV-Associated Lipodystrophy Syndrome
4. HIV Infections (HIV Infection)
5. Fibrosis (Cirrhosis)

Related Drugs and Biologics

1. Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)
2. Hormones (Hormone)
3. Leptin
4. Enzymes
5. Transaminases (Aminotransferases)
6. Insulin (Novolin)
7. Biomarkers (Surrogate Marker)
8. Growth Hormone (Somatotropin)
9. tesamorelin
10. Voriconazole (Vfend)

Related Therapies and Procedures

1. Subcutaneous Injections
2. Therapeutics
3. Withholding Treatment